Pennon Group H1 Underlying Pretax Profit Declines; Underlying Revenue Up 9.3%

Pennon Group plc (PNN.L) reported underlying profit before tax of 22.5 million pounds for the half year ended 30 September 2022 compared to 90.4 million pounds, prior year. Adjusted EPS declined to 7.9 pence from 30.6 pence. The Group said the reduction reflects the near-term pressures on earnings from inflation driven power pricing and financing costs, net of other cost efficiencies, as flagged.

Profit before tax was 20.9 million pounds compared to 79.9 million pounds, last year. Profit per share was 6.9 pence compared to a loss of 6.3 pence. First half revenue was 425.5 million pounds, an increase of 9.3%.

For first half, the Board has declared an interim dividend of 12.96 pence, an increase of 10.8% on prior year. The interim dividend will be paid on 5 April 2023 to shareholders on the register on 27 January 2023.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC announced recall of thousands of children's Robes made in China and sold exclusively on Amazon.com by various companies. The recalled robes fail to meet the federal flammability standards for children's sleepwear, posing a risk of burn injuries to children. Further, citing the same concerns, Paper Cape children's pajamas manufactured in Peru ... Health services company Cigna Corp. reported Friday higher profit in its fourth quarter reflecting growth in both Evernorth and Cigna Healthcare segments. Adjusted earnings and topline beat market estimates. Looking ahead for fiscal 2023, the company projects adjusted earnings and adjusted revenues to be higher than last year, but below market view. French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
Follow RTT